Home
Resources
Publications
Fucoidan From Fucus Vesiculosus Inhibits New Blood Vessel Formation and Breast Tumor Growth in Vivo

Fucoidan From Fucus Vesiculosus Inhibits New Blood Vessel Formation and Breast Tumor Growth in Vivo

Catarina Oliveira, Sara Granja, Nuno M Neves, Rui L Reis, Fátima Baltazar, Tiago H Silva, Albino Martins

Carbohydr Polym. 2019 Nov 1;223:115034.

PMID: 31426965

Abstract:

Fucoidan is a marine-origin sulfated polysaccharide that can show anticancer activity, to which both pro- and anti-angiogenic responses have been reported. Due to this unpredictability, the angiogenic potential of an effective anticancer crude fucoidan (CF), at a concentration of 0.5 mg mL-1, was evaluated. Tube formation assays demonstrated that CF, either administered while endothelial cells seeding or after their adhesion, migration and organization, inhibited or disrupted the formation of tubular-like structures, respectively. Although CF did not significantly reduced vascular endothelial growth factor (VEGF) secretion, it significantly reduced the expression of platelet-derived growth factor (PDGF), compromising the blood vessels maturation. Two chicken embryo chorioallantoic membrane (CAM) assays were performed: one without tumor (CAM I) and the other with an onplanted tumor mass (CAM II); the CF injection reduced the number of blood of vessels and significantly decreased the tumor size, respectively. In vitro and in vivo results support the effectiveness of fucoidan as a natural antitumor therapeutic agent.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP9072199-A	Fucoidan from Fucus vesiculosus		9072-19-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: